Table 2.
Results of standard liver function tests of healthy controls and patients with liver diseases
| Healthy controls (n=53) | Acute viral hepatitis (n=14) | Cirrhosis with portal hypertension (n=33) | Leptospirosis (n=14) | Sepsis (n=15) | Left ventricular failure (n=9) | Falciparum malaria (n=10) | |
| Total bilirubin (mg/dL) | 0.80±0.28 | 8.22±6.01** | 4.64±4.19** | 3.62±3.2 | 2.10±0.69 | 1.57±1.18 | 3.88±1.8 |
| Direct bilirubin (mg/dL) | 0.34±0.16 | 4.9±4.06** | 2.8±2.5** | 3.12±2.32 | 0.88±0.69 | 0.6±0.5 | 2.5±1.21 |
| AST (U/L) | 18.2±4.01 | 244±105.7** | 104.82±74.92* | 219.4±209.1** | 227.5±184.3** | 52±15.21 | 85.20±15.8** |
| ALT (U/L) | 15.02±3.9 | 219.6±88.2** | 65.82±54.92* | 116.3±84.4** | 151.5±106.2** | 48±31.01 | 87.4±46.6* |
| ALP (U/L) | 75.7±2.41 | 167±62.75* | 155.5±62* | 279±186.9** | 223.4±158** | 175±125.3 | 209±33.53** |
| Total protein (g/dL) | 7.14±0.29 | 7.45±0.65 | 7.61±0.9 | 7.12±1.05 | 5.5±0.17** | 6.30±0.8 | 5.88±0.72** |
| Albumin (g/dL) | 3.64±0.23 | 3.7±0.77 | 3.26±0.86 | 3.25±1.12 | 2.24±0.37** | 2.76±0.45* | 2.66±0.32** |
| Globulin (g/dL) | 3.5±0.17 | 3.52±0.08 | 4.38±1.09** | 3.87±0.75 | 3.26±0.44 | 3.6±0.49 | 3.22±0.94 |
**
P<0.001 compared to normal controls
*
P<0.05 compared to normal controls; Data expressed as mean±SD